• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰东北部泰恩赛德北部一个地区帕金森病的患病率。

The prevalence of Parkinson's disease in an area of North Tyneside in the North-East of England.

作者信息

Porter Bob, Macfarlane Rob, Unwin Nigel, Walker Richard

机构信息

Parkinson's Disease Service, Northumbria Healthcare NHS Trust, Tyne and Wear, Newcastle upon Tyne, UK.

出版信息

Neuroepidemiology. 2006;26(3):156-61. doi: 10.1159/000091657. Epub 2006 Feb 21.

DOI:10.1159/000091657
PMID:16493203
Abstract

OBJECTIVES

UK prevalence studies have demonstrated prevalence rates for Parkinson's disease (PD) of 108 to 164 cases per 100,000. we aimed to calculate the prevalence of PD in an area of the North-East of England.

MATERIAL AND METHODS

A case finding methodology was used to identify cases in North Tyneside with a population of 108,597 at the 2001 UK census.

RESULTS

161 cases were identified giving crude and age-adjusted prevalence estimates of 148 cases (95% CI 124-174) and 139 cases (95% CI 116-162) per 100,000, respectively. The mean age was 74.1 years (range 44-96 years) with mean disease duration of 5.6 years.

CONCLUSIONS

The prevalence of PD in North Tyneside is comparable with that of the rest of the UK. The prevalence of PD in the UK appears not to have changed greatly over the last 30 years.

摘要

目的

英国的患病率研究表明,帕金森病(PD)的患病率为每10万人中有108至164例。我们旨在计算英格兰东北部一个地区的PD患病率。

材料与方法

采用病例发现方法,在2001年英国人口普查中识别泰恩赛德北部地区的病例,该地区人口为108,597人。

结果

共识别出161例病例,粗患病率和年龄调整患病率估计分别为每10万人中有148例(95%置信区间124 - 174)和139例(95%置信区间116 - 162)。平均年龄为74.1岁(范围44 - 96岁),平均病程为5.6年。

结论

泰恩赛德北部地区的PD患病率与英国其他地区相当。在过去30年里,英国PD的患病率似乎没有太大变化。

相似文献

1
The prevalence of Parkinson's disease in an area of North Tyneside in the North-East of England.英格兰东北部泰恩赛德北部一个地区帕金森病的患病率。
Neuroepidemiology. 2006;26(3):156-61. doi: 10.1159/000091657. Epub 2006 Feb 21.
2
The prevalence of Parkinson's disease in a rural area of North-East England.英格兰东北部农村地区帕金森病的患病率。
Parkinsonism Relat Disord. 2010 Nov;16(9):572-5. doi: 10.1016/j.parkreldis.2010.07.002. Epub 2010 Jul 31.
3
Population prevalence and incidence of Parkinson's disease in an Australian community.澳大利亚某社区帕金森病的人群患病率和发病率。
Intern Med J. 2007 Dec;37(12):812-4. doi: 10.1111/j.1445-5994.2007.01433.x. Epub 2007 Jun 11.
4
[Estimation of the prevalence of Parkinson's disease in Asturia, Spain. A pharmacoepidemiological study of the consumption of antiparkinson drugs].[西班牙阿斯图里亚斯地区帕金森病患病率的估计:一项抗帕金森药物消费的药物流行病学研究]
Rev Neurol. 2000;31(11):1001-6.
5
A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease.一个用于确定泰国帕金森病分布和流行情况的全国性登记处:城市化和农药作为帕金森病危险因素的影响。
Neuroepidemiology. 2011;37(3-4):222-30. doi: 10.1159/000334440. Epub 2011 Dec 1.
6
Cross-sectional survey of Parkinson's disease and parkinsonism in a rural area of the United Kingdom.英国某农村地区帕金森病和帕金森综合征的横断面调查。
Mov Disord. 2005 Aug;20(8):995-8. doi: 10.1002/mds.20489.
7
Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan.城乡帕金森病患病率的差异:台湾一项基于人群的研究。
Neuroepidemiology. 2009;33(4):350-7. doi: 10.1159/000254572. Epub 2009 Nov 4.
8
Use of a refined drug tracer algorithm to estimate prevalence and incidence of Parkinson's disease in a large israeli population.使用改良的药物示踪算法估计大型以色列人群中帕金森病的患病率和发病率。
J Parkinsons Dis. 2011;1(1):35-47. doi: 10.3233/JPD-2011-11024.
9
Prevalence of Parkinson's disease in Northern Jordan.约旦北部帕金森病的患病率。
Clin Neurol Neurosurg. 2009 Dec;111(10):812-5. doi: 10.1016/j.clineuro.2009.08.010. Epub 2009 Sep 5.
10
Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.日本25年间帕金森病患病率和发病率的变化。
Neuroepidemiology. 2009;32(4):263-9. doi: 10.1159/000201565. Epub 2009 Feb 11.

引用本文的文献

1
Dopamine transporter single photon emission computed tomography (DaT-SPECT) use in the diagnosis and clinical management of parkinsonism: an 8-year retrospective study.多巴胺转运体单光子发射计算机断层扫描(DaT-SPECT)在帕金森病的诊断和临床管理中的应用:一项 8 年回顾性研究。
J Neurol. 2023 May;270(5):2550-2558. doi: 10.1007/s00415-023-11563-y. Epub 2023 Feb 16.
2
Towards accurate and unbiased imaging-based differentiation of Parkinson's disease, progressive supranuclear palsy and corticobasal syndrome.迈向基于成像的帕金森病、进行性核上性麻痹和皮质基底节综合征的准确且无偏倚的鉴别诊断。
Brain Commun. 2020;2(1):fcaa051. doi: 10.1093/braincomms/fcaa051. Epub 2020 Apr 27.
3
Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset.
线粒体功能相关基因会增加患帕金森病的风险,并导致发病年龄较晚。
NPJ Parkinsons Dis. 2019 May 22;5:8. doi: 10.1038/s41531-019-0080-x. eCollection 2019.
4
Remarkably Few Sputum Cultures from People with Parkinson's Disease during Hospital In-Patient Admission.帕金森病患者住院期间痰培养结果出奇地少。
Parkinsons Dis. 2015;2015:378967. doi: 10.1155/2015/378967. Epub 2015 Feb 5.
5
The rise of mortality from mental and neurological diseases in Europe, 1979-2009: observational study.1979 - 2009年欧洲精神和神经疾病死亡率的上升:观察性研究
BMC Public Health. 2014 Aug 13;14:840. doi: 10.1186/1471-2458-14-840.
6
The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease.深部脑刺激联合最佳药物治疗与单纯最佳药物治疗在晚期帕金森病中的成本效益。
J Neurol. 2014 Jan;261(1):106-16. doi: 10.1007/s00415-013-7148-z. Epub 2013 Oct 25.
7
Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.利用全基因组复杂性状分析量化帕金森病中的“遗传缺失”。
Hum Mol Genet. 2012 Nov 15;21(22):4996-5009. doi: 10.1093/hmg/dds335. Epub 2012 Aug 13.
8
A cross-sectional study of the nutritional status of community-dwelling people with idiopathic Parkinson's disease.社区居住的特发性帕金森病患者营养状况的横断面研究。
BMC Neurol. 2010 Dec 30;10:124. doi: 10.1186/1471-2377-10-124.
9
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.慢性神经退行性疾病中的内源性神经保护:特别关注犬尿氨酸途径。
J Cell Mol Med. 2011 Apr;15(4):701-17. doi: 10.1111/j.1582-4934.2010.01237.x.
10
Is Parkinson's disease-related mortality declining?帕金森病相关死亡率正在下降吗?
Eur J Neurol. 2009 Sep;16(9):964-5. doi: 10.1111/j.1468-1331.2009.02711.x. Epub 2009 Jun 30.